Muscular Dystrophy-dystroglycanopathy (congenital With Brain And Eye Anomalies), Type A, 12; Mddga12
Description
Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies (type A) is an autosomal recessive disorder with congenital muscular dystrophy resulting in muscle weakness early in life and brain and eye anomalies. It is usually associated with delayed psychomotor development and shortened life expectancy. The phenotype includes the alternative clinical designations Walker-Warburg syndrome (WWS) and muscle-eye-brain disease (MEB). The disorder represents the most severe end of a phenotypic spectrum of similar disorders resulting from defective glycosylation of alpha-dystroglycan (DAG1 ), collectively known as dystroglycanopathies (summary by Stevens et al., 2013).For a general phenotypic description and a discussion of genetic heterogeneity of muscular dystrophy-dystroglycanopathy type A, see MDDGA1 (OMIM ).
Genes related to Muscular Dystrophy-dystroglycanopathy (congenital With Brain And Eye Anomalies), Type A, 12; Mddga12
- POMK
Clinical Features
Top most frequent phenotypes and symptoms related to Muscular Dystrophy-dystroglycanopathy (congenital With Brain And Eye Anomalies), Type A, 12; Mddga12
- Seizures
- Global developmental delay
- Generalized hypotonia
- Hearing impairment
- Microcephaly
- Scoliosis
- Sensorineural hearing impairment
- Muscle weakness
- Cataract
- Flexion contracture
And another 37 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Muscular Dystrophy-dystroglycanopathy (congenital With Brain And Eye Anomalies), Type A, 12; Mddga12 Is also known as walker-warburg syndrome or muscle-eye-brain disease, pomk-related.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Muscular Dystrophy-dystroglycanopathy (congenital With Brain And Eye Anomalies), Type A, 12; Mddga12 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Neuromuscular Disorders Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RYR1, BIN1, SCN4A, SGCA, SGCB, SGCD, SGCE, SGCG, SLC25A4, SUCLA2, SUCLG1, TWNK, TCAP, TIA1, TK2, TNNI2, TNNT1, TPM2, TPM3, MYOT , (...)
View the complete list with 124 more genes
Specificity
1 %
Genes
100 % |
Neuromuscular Disorders Sequencing Panel.
By Genetic Services Laboratory University of Chicago (United States).
RYR1, BIN1, SCN4A, SGCA, SGCB, SGCD, SGCG, SNAP25, STIM1, SYT2, TCAP, TNNT1, TNXB, TPM2, TPM3, MYOT, TTN, VCP, ACTA1, RXYLT1 , (...)
View the complete list with 91 more genes
Specificity
1 %
Genes
100 % |
Cerebral Cortical Malformation Sequencing Panel.
By Genetic Services Laboratory University of Chicago (United States).
SNAP29, TUBA8, TUBB2A, TUBG1, VLDLR, ACTB, RAB18, ACTG1, B3GNT2, B4GAT1, CCND2, ARFGEF2, TBC1D20, RAB3GAP1, RAB3GAP2, NDE1, CDK5, FKRP, ARX, ATP6V0A2 , (...)
View the complete list with 34 more genes
Specificity
2 %
Genes
100 % |
Lissencephaly Sequencing Panel.
By Genetic Services Laboratory University of Chicago (United States).
SNAP29, TUBG1, VLDLR, ACTB, RXYLT1, ACTG1, B4GAT1, NDE1, CDK5, FKRP, ARX, ATP6V0A2, POMGNT1, POMT2, TUBA1A, TUBB3, TUBB, GMPPB, SRD5A3, POMGNT2 , (...)
View the complete list with 16 more genes
Specificity
3 %
Genes
100 % |
Comprehensive Lissencephaly Panel.
By Genetic Services Laboratory University of Chicago (United States).
SNAP29, TUBG1, VLDLR, ACTB, RXYLT1, ACTG1, B4GAT1, CDK5, FKRP, ARX, ATP6V0A2, POMGNT1, POMT2, TUBA1A, TUBB3, TUBB, GMPPB, SRD5A3, POMK, DCX , (...)
View the complete list with 14 more genes
Specificity
3 %
Genes
100 % |
Cobblestone Lissencephaly Panel.
By Genetic Services Laboratory University of Chicago (United States).
SNAP29, RXYLT1, B4GAT1, FKRP, ATP6V0A2, POMGNT1, POMT2, GMPPB, SRD5A3, POMK, B3GALNT2, FKTN, ISPD, LAMA2, LAMB1, LARGE1, POMT1
Specificity
6 %
Genes
100 % |
Congenital Muscular Dystrophy Deletion/Duplication Analysis.
By Genetic Services Laboratory University of Chicago (United States).
RYR1, RXYLT1, SELENON, SYNE1, FKRP, POMGNT1, CHKB, POMT2, COL6A1, COL6A2, COL6A3, TRAPPC11, POMGNT2, POMK, DAG1, B3GALNT2, DPM2, DPM3, FKTN, ISPD , (...)
View the complete list with 6 more genes
Specificity
4 %
Genes
100 % |
Congenital Muscular Dystrophy Sequencing Panel.
By Genetic Services Laboratory University of Chicago (United States).
RYR1, RXYLT1, SELENON, SYNE1, FKRP, POMGNT1, CHKB, POMT2, COL6A1, COL6A2, COL6A3, TRAPPC11, POMGNT2, POMK, DAG1, B3GALNT2, DPM1, DPM2, DPM3, FKTN , (...)
View the complete list with 7 more genes
Specificity
4 %
Genes
100 % |
You can get up to 40 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like TOWNES-BROCKS SYNDROME 1; TBS1 SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36